⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAT News
Phathom Pharmaceuticals, Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Is Investigating Phathom Pharmaceuticals, Inc. (PHAT) And Encourages Stockholders to Connect
accessnewswire.com
PHAT
Phathom Pharmaceuticals, Inc. (PHAT) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
PHAT
PHAT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Phathom Pharmaceuticals
prnewswire.com
PHAT
Levi & Korsinsky Announces Investigation of Securities Claims Against Phathom Pharmaceuticals, Inc. (PHAT)
accessnewswire.com
PHAT
Phathom Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Phathom Pharmaceuticals (PHAT)
prnewswire.com
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
PHAT
Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026
globenewswire.com
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
globenewswire.com
PHAT